TipRanks
Go Ultimate55% OFF

Lotus Bio-Technology Development (LBTD) Financial Statements

Lotus Bio-Technology Development Financial Overview

Lotus Bio-Technology Development's market cap is currently $783. The company's EPS TTM is $-0.01; its P/E ratio is -50.00; Lotus Bio-Technology Development has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 17
Income Statement
Total Revenue$ 0.00
Gross Profit$ 0.00
Operating Income$ -19.55K
EBITDA$ -18.46K
Net Income$ -19.55K
Balance Sheet
Cash & Short-Term Investments$ 0.00
Total Assets$ 0.00
Total Debt$ 6.45K
Net Debt$ 6.45K
Total Liabilities$ 80.86K
Stockholders' Equity$ -61.31K
Cash Flow
Free Cash Flow$ -17.75K
Operating Cash Flow$ -17.75K
Investing Cash Flow$ 0.00
Financing Cash Flow$ 17.75K

Currency in USD

Lotus Bio-Technology Development Earnings and Revenue History

-24K-16K-8K00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017RevenueEarningsProfit Margin

Lotus Bio-Technology Development Debt to Assets

030K60K90K0 %0.4 %0.8 %1.2 %LiabilitiesDebt to Assets2017AssetsLiabilitiesDebt to Assets

Lotus Bio-Technology Development Cash Flow

-20K-10K010K20K2017OperatingInvestingFinancing

Lotus Bio-Technology Development Forecast EPS vs Actual EPS

0Q3 18EPS EstimateBeatMiss